Target intelligence / Profile preview

Suppression of effector T cell function by regulatory T cells

Molecular classification
Other (Immunological process)
01

Overview

Regulatory T cells (Tregs) are a specialized subset of CD4+ T cells required for immune homeostasis, self-tolerance, and the prevention of autoimmunity. Tregs suppress the activation, proliferation, and effector functions of CD4+ and CD8+ T cells mainly through secretion of immunoregulatory cytokines (TGF-β, IL-10, IL-35), competition for IL-2, direct cell contact (CTLA-4, LAG3, TIGIT), induction of apoptosis, and metabolic disruption. Treg-mediated suppression is essential for preventing excessive immune activation and autoimmunity but may also limit beneficial anti-tumor or anti-infective immune responses. This “target” describes a fundamental immunological process, not an individual molecular entity.

Other names
Treg-mediated immune suppressionRegulatory T cell suppressionTreg suppression of effector T cells
02

Mechanism of action

Secretion of inhibitory cytokines (TGF-β, IL-10, IL-35); Consumption of growth factors (IL-2 ‘sink’ mechanism); Cell contact-dependent suppression (CTLA-4, LAG3, TIGIT); Metabolic disruption (CD39/CD73/adenosine; cAMP transfer); Induction of apoptosis (Granzyme B/perforin)

03

Biological functions

Immune regulationMaintenance of self-toleranceSuppression of inflammationInhibition of immune effector cell proliferation and function
04

Disease associations

Autoimmune diseaseInflammatory diseaseCancer (tumor immune evasion)Infection
05

Safety considerations

Inhibition of beneficial immune responses (may facilitate tumor progression or chronic infection)Risk of autoimmunity (with excessive Treg depletion or dysfunction)Increased infection (if immune suppression is excessive)

Beyond the preview

Go deeper on Suppression of effector T cell function by regulatory T cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Suppression of effector T cell function by regulatory T cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call